ALKT vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

ALKT

29.6
AI Score
VS
DBD Wins

DBD

59.7
AI Score

Investment Advisor Scores

ALKT

30score
Recommendation
SELL

DBD

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ALKT DBD Winner
Forward P/E 0 12.1655 Tie
PEG Ratio 0 0 Tie
Revenue Growth 15.9% 1.7% ALKT
Earnings Growth 0.0% 34.2% DBD
Tradestie Score 29.6/100 59.7/100 DBD
Profit Margin -9.2% 2.9% DBD
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD DBD

Relative Price Performance (Last 90 Days)

ALKT 1M: +25.2% · 3M: +20.8% DBD 1M: -19.6% · 3M: -3.4%

Current Technical Phase

ALKT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 64

RSI (14): 64.4 · Price: $20.38

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $69.94

Fundamentals Snapshot

Metric ALKT DBD
Market Cap
Forward P/E 18.8 10.0
Trailing P/E 22.3
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.6% 0.3%
Operating Margin -0.1% 0.1%
EPS -0.43 3.04
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.